but also whether the effects of accurate edits will be the ones we intend. We already know that some of the gene edits scientists are considering for clinical use have secondary effects. For instance, editing an embryo’s CCR5 gene might make the resulting human resistant to HIV but more susceptible to the West Nile virus.
